| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 148 |
| 1 | ETANERCEPT | 147 |
| 2 | LEFLUNOMIDE | 147 |
| 3 | ABATACEPT | 132 |
| 4 | TOCILIZUMAB | 131 |
| 5 | METHOTREXATE | 130 |
| 6 | TOFACITINIB | 118 |
| 7 | HYDROXYCHLOROQUINE SULFATE | 104 |
| 8 | INFLIXIMAB | 95 |
| 9 | SULFASALAZINE | 87 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLD | 69 | 0.0185 |
| 1 | ELETRIPTAN HYDROBROMIDE | 22 | 0.0032 |
| 2 | LEFLUNOMIDE | 147 | 0.0019 |
| 3 | TOCILIZUMAB | 131 | 0.0018 |
| 4 | SULFASALAZINE | 87 | 0.0016 |
| 5 | HYDROXYCHLOROQUINE SULFATE | 104 | 0.0015 |
| 6 | ABATACEPT | 132 | 0.0014 |
| 7 | CIDOFOVIR ANHYDROUS | 1 | 0.0011 |
| 8 | PROBENECID | 1 | 0.0010 |
| 9 | TOFACITINIB | 118 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 158 |
| 1 | Antirheumatic Agent [EPC] | 147 |
| 2 | Selective T Cell Costimulation Modulator [EPC] | 132 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 131 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 130 |
| 5 | Aminosalicylate [EPC] | 87 |
| 6 | Standardized Chemical Allergen [EPC] | 69 |
| 7 | Corticosteroid [EPC] | 50 |
| 8 | Purine Antimetabolite [EPC] | 41 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 35 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Standardized Chemical Allergen [EPC] | 69 | 0.0060 |
| 1 | Antirheumatic Agent [EPC] | 147 | 0.0019 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 131 | 0.0017 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 132 | 0.0014 |
| 4 | Aminosalicylate [EPC] | 87 | 0.0010 |
| 5 | Purine Antimetabolite [EPC] | 41 | 0.0006 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 130 | 0.0004 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 158 | 0.0002 |
| 8 | Xanthine Oxidase Inhibitor [EPC] | 17 | 0.0001 |
| 9 | Tetracycline-class Drug [EPC] | 5 | 0.0001 |